I'm LongbridgeAI, I can summarize articles.Top analysts have upgraded several stocks, including Tesla (TSLA), which was upgraded from Sell to Neutral by UBS analyst Joseph Spak, maintaining a price target of $352. Other notable upgrades include Ford (F) from Neutral to Buy, Biogen (BIIB) from Neutral to Overweight, VF Corp (VFC) from Neutral to Buy, and Crocs (CROX) from Neutral to Buy. Analysts suggest considering TSLA stock based on these ratings.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- UBS analyst Joseph Spak upgraded Ford Motor Co (NYSE:F) from Neutral to Buy and maintained the price target of $15. Ford shares closed at $12.16 on Monday. See how other analysts view this stock.
- Piper Sandler analyst David Amsellem upgraded Biogen Inc (NASDAQ:BIIB) from Neutral to Overweight and raised the price target from $177 to $214. Biogen shares closed at $176.36 on Monday. See how other analysts view this stock.
- UBS analyst Joseph Spak upgraded Tesla Inc (NASDAQ:TSLA) from Sell to Neutral and maintained the price target of $352. Tesla shares closed at $352.42 on Monday. See how other analysts view this stock.
- Seaport Global analyst Mitch Kummetz upgraded VF Corp (NYSE:VFC) from Neutral to Buy and announced a $24 price target. VF shares closed at $18.44 on Monday. See how other analysts view this stock.
- Seaport Global analyst Mitch Kummetz upgraded Crocs Inc (NASDAQ:CROX) from Neutral to Buy and announced a $135 price target. Crocs shares closed at $100.22 on Monday. See how other analysts view this stock.
Considering buying TSLA stock? Here’s what analysts think:
Photo via Shutterstock